arginine has been researched along with Diabetes Insipidus, Neurogenic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atila, C; Christ-Crain, M; Garrahy, A; Gildroy, P; Hamza, M; Hemkens, LG; Hunter, SJ; Karavitaki, N; Levy, MJ; Loughrey, PB; Newell-Price, J; Pal, A; Refardt, J; Sherlock, M; Thompson, CJ; Verbalis, JG; Wass, JAH; Winzeler, B | 1 |
| Binder, G; Peter, A; Schweizer, R; Weber, K | 1 |
| Avila-Blanco, ME; Calvillo-Robedo, A; González-Blas, D; Muñoz-Ortega, MH; Navarro-Gonzalez, YD; Quintanar-Stephano, A; Valdez-Urias, F; Ventura-Juarez, J | 1 |
| Ilie, MD; Raverot, G | 1 |
| Atila, C; Christ-Crain, M; Eckert, A; Heinrichs, M; Holze, F; Hutter, N; Liechti, ME; Murugesu, R; Rommers, N; Sailer, CO; Varghese, N | 1 |
| Moodley, N | 1 |
| Newell-Price, J | 1 |
| Bologna, K; Cesana-Nigro, N; Christ-Crain, M; Imber, C; Refardt, J; Vogt, DR; Winzeler, B | 1 |
1 review(s) available for arginine and Diabetes Insipidus, Neurogenic
| Article | Year |
|---|---|
Copeptin analysis in endocrine disorders.
Topics: Adult; Arginine; Arginine Vasopressin; Child; Diabetes Insipidus, Neurogenic; Glycopeptides; Humans | 2023 |
1 trial(s) available for arginine and Diabetes Insipidus, Neurogenic
| Article | Year |
|---|---|
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Topics: Arginine; Case-Control Studies; Cross-Over Studies; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Double-Blind Method; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin | 2023 |
6 other study(ies) available for arginine and Diabetes Insipidus, Neurogenic
| Article | Year |
|---|---|
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Topics: Adolescent; Adult; Arginine; Child; Cross-Sectional Studies; Deamino Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Hyponatremia; Internet; Male; Middle Aged; Morbidity; Quality of Life | 2022 |
Arginine-stimulated copeptin in children and adolescents.
Topics: Adolescent; Arginine; Child; Diabetes Insipidus, Neurogenic; Glycopeptides; Humans; Retrospective Studies | 2023 |
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
Topics: Anastomosis, Surgical; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Cricetinae; Diabetes Insipidus, Neurogenic; Liver Cirrhosis; Rats; Receptors, Vasopressin | 2023 |
Oxytocin deficiency in patients with arginine vasopressin deficiency (central diabetes insipidus).
Topics: Arginine; Deamino Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Humans; Oxytocin | 2023 |
Testing for Arginine Vasopressin Deficiency.
Topics: Arginine; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Humans | 2023 |
Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
Topics: Adrenocorticotropic Hormone; Adult; Arginine; Diabetes Insipidus, Neurogenic; Female; Glycopeptides; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Polydipsia, Psychogenic; Prospective Studies; Young Adult | 2020 |